| Literature DB >> 35956939 |
Marta Sánchez1, Isabel Ureña-Vacas1, Elena González-Burgos1, Pradeep Kumar Divakar1, Maria Pilar Gómez-Serranillos1.
Abstract
The genus Cetraria s. str. (Parmeliaceae family, Cetrarioid clade) consists of 15 species of mostly erect brown or greenish yellow fruticose or subfoliose thallus. These Cetraria species have a cosmopolitan distribution, being primarily located in the Northern Hemisphere, in North America and in the Eurasia area. Phytochemical analysis has demonstrated the presence of dibenzofuran derivatives (usnic acid), depsidones (fumarprotocetraric and protocetraric acids) and fatty acids (lichesterinic and protolichesterinic acids). The species of Cetraria, and more particularly Cetraria islandica, has been widely employed in folk medicine for the treatment of digestive and respiratory diseases as decoctions, tinctures, aqueous extract, and infusions. Moreover, Cetraria islandica has had an important nutritional and cosmetic value. These traditional uses have been validated in in vitro and in vivo pharmacological studies. Additionally, new therapeutic activities are being investigated, such as antioxidant, immunomodulatory, cytotoxic, genotoxic and antigenotoxic. Among all Cetraria species, the most investigated by far has been Cetraria islandica, followed by Cetraria pinastri and Cetraria aculeata. The aim of the current review is to update all the knowledge about the genus Cetraria covering aspects that include taxonomy and phylogeny, morphology and distribution, ecological and environmental interest, phytochemistry, traditional uses and pharmacological properties.Entities:
Keywords: Cetraria; botany; lichens; pharmacology; phytochemistry; traditional uses
Mesh:
Substances:
Year: 2022 PMID: 35956939 PMCID: PMC9370490 DOI: 10.3390/molecules27154990
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Cetraria islandica (L.) Ach. Photograph was kindly provided by prof. Divakar.
Morphological features of species from the genus Cetraria s. str.
| Morphology | |||||
|---|---|---|---|---|---|
| Type of Thallus | Color | Structures | Substrate | References | |
| Fruticose | Thallus: brown to black. | Pseudocyphellae abundant Isidia and soredia absent | Terricolous | [ | |
| Foliose | Thallus: pale yellow | Soredia are white, granular | Terricolous | [ | |
| Fruticose | Thallus: Upper surface dark. Lower surface yellowish brown to dark brown. | Marginal pseudocyphellae | Terricolous | [ | |
| Fruticose | Thallus: olive or brown (to almost black). | Soredia absent | Corticolous | [ | |
| Fruticose | Thallus: dark brown to paler brown | Pseudocyphellae abundant on the margins | Terricolous | [ | |
| Foliose | Thallus: upper surface greenish or greenish-brown, lower surface is greyish-white or light brownish. | Laminal pseudocyphellae | Terricolous | [ | |
| Fruticose | Thallus: dark brown. | Apothecia not seen | Musciolous | [ | |
| Fruticose | Thallus: upper side pale brown, underside paler. | Apothecia not seen | Terricolous | [ | |
| Fruticose | Thallus: Brown to | Pseudocyphellae scattered, | Terricolous | [ | |
| Fructicose | Thallus: brown to black. | Apothecia unknown | Terricolous | [ | |
| Foliose | Thallus: upper side dark brown or olive-brown, lower side pale brown. | Apothecia present | Terricolous | [ | |
| Fruticose | Thallus: olive or brown (to almost black). | Pseudocyphellae exclusively on the underside | Epilithic | [ | |
| Fruticose | Thallus: Dark brown. | Pseudocyphellae present | Terricolous | [ | |
| Fruticose | Thallus: reddish, brown to dark brown or almost black. | Apothecia usually absent | Terricolous | [ | |
| Fruticose | Thallus: brownish black | Pycnidium present | Terricolous | [ | |
| Fruticose | Thallus: brown to almost black | Marginal pseudocyphellae absent. | Corticolous | [ | |
| Fruticose | Thallus: black, brown to light brown | Pseudocyphellae depressed or poorly visible | Terricolous | [ | |
Distribution patterns of Cetraria lichen species.
| Lichen Species | Distribution Pattern | Distribution Areas | References |
|---|---|---|---|
| Cosmopolitan | Four continents and many oceanic islands. | [ | |
| Endemic | Baikal region, Russia | [ | |
| Endemic | South-eastern Australia | [ | |
| Endemic | Western parts of the Iberian Peninsula and Italy | [ | |
| Endemic (each subspecies separated geographically) | Europe and Asia | [ | |
| Bipolar | High latitudes in northern and southern hemispheres | [ | |
| Amphi-Beringian | Eastern Siberia and Alaska | [ | |
| Amphi-Beringian | North America (from Alaska through upper Canada) | [ | |
| Amphi-Beringian | Eastern Siberia, Interior Alaska | [ | |
| Cosmopolitan | Four continents and many oceanic islands. | [ | |
| Endemic | Isolated localities at high elevations in the Great Himalayas | [ | |
| Circumpolar | High Arctic (Alaska, Canada) | [ | |
| Circumboreal | Boreal regions of the northern hemisphere. | [ | |
| Endemic | Alpine areas of the Alps—Austria, Italy, Switzerland | [ | |
| Endemic | Central part of South America | [ | |
| Endemic | Northern Baikal region of central Siberia | [ | |
| Circumboreal | Boreal forest and in the tundras of the Arctic | [ | |
| Endemic | Semiarid Eurasian steppe biomes from Kazakhstan to Iran and Ukraine. | [ |
Figure 2Chemical structures of Cetraria species secondary metabolites.
Chemical composition of Cetraria spp.
| Lichen Species | Chemical Composition | References |
|---|---|---|
| Lichesterinic acid, protolichesterinic acid | [ | |
| Major: usnic acid, isonephrosterinic acid | [ | |
| Lichesterinic acid, protolichesterinic acid, ursolic acid. | [ | |
| Lichesterinic protolichesterinic acid | [ | |
| Fumarprotocetraric acid, protocetraric acid, protolichesterinic acid, usnic acid | [ | |
| Protolichesterinic acid, rangiformic acid | [ | |
| Fumarprotocetraric acid. | [ | |
| Lichesterinic acid, protolichesterinic acid | [ | |
| Protolichesterinic acid, rangiformic acid, secalonic acid | [ | |
| Protolichesteric and rangiformic acids | ||
| Lichesterinic acid, protolichesterinic acid, secalonic acid | [ | |
| Lichesterinic acid and protolichesterinic acid. | [ | |
| Usnic acid, lichesterinic acid, protolichesterinic acid, norstictic acid | [ |
Pharmacological activities of Cetraria spp.
| Lichen Species | Extracts/Active Compounds | Experimental Model | Activities | Results | References |
|---|---|---|---|---|---|
| Diethyl ether extract Ethanol extract | Gram-positive: | Antibacterial | Antimicrobial activity against | [ | |
| Diethyl ether extract | Antifungal | No antifungal activity detected | [ | ||
| Acetone extract | TA98 and TA100 strains of | Antigenotoxicity | ↑ Inhibition of frameshift mutations in TA98 than in TA100 | [ | |
| Methanol extract | Antigenotoxicity | Antimutagenic activity against | [ | ||
| Methanol extract | Radical scavenging activity | Antioxidant | Methanol extract >>> ethyl acetate extract | [ | |
| Methanol extract | Human lymphocytes cells | Antioxidant | ↑ SOD, GPX, MDA levels | [ | |
| Acetone extract | HeLa cells, A549 cells and 5RP7 cells | Cytotoxic | ↓ Cell viability | [ | |
| Methanol extract | Genotoxicity | No activity | [ | ||
| Methanol extract | Antibacterial | Light petrolatum extract > Acetone extract | [ | ||
| Methanol extract | Gram-positive: | Antibacterial | Antimicrobial activity against all bacteria | [ | |
| Methanol extract | Antifungal | Antifungical activity against all fungi | [ | ||
| Aqueous extract | Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats | Antidiabetic | Slight insulin increase | [ | |
| Aqueous extract | Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats | Antidiabetic | No body weight change | [ | |
| Aqueous Extract | Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats | Antidiabetic | ↓ TOS | [ | |
| Aqueous extract | BSA-induced arthritis in rats | Anti-inflammatory | ↓ reduction in the diameter between the right and left knee | [ | |
| Aqueous extract | Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats | Antioxidant | ↑ SOD and CAT | [ | |
| Aqueous extract | Streptozotocin-induced Diabetes Mellitus type 1 Sprague-Dawley rats | Antioxidant | ↑ SOD, GSH | [ | |
| Aqueous extract | Human erythrocytes with type 1 diabetes mellitus | Antioxidant | ↑ SOD, CAT and GPx | [ | |
| Methanol extract | Blood lymphocytes from human nonsmoking healthy volunteers | Antioxidant | ↑ SOD and GPx | [ | |
| Aqueous extract | Radical scavenging activity | Antioxidant | 96–100% inhibition upon lipid peroxidation of linoleic acid system | [ | |
| Ethanol extract | Radical scavenging activity | Antioxidant | DPPH, FRAP and ABTS | [ | |
| Methanol extract | Radical scavenging activity | Antioxidant | DPPH (IC50 678.3 μg/mL) | [ | |
| Melanin | Radical scavenging activity | Antioxidant | DPPH (IC50 405 μg/mL) | [ | |
| Protolichesterinic acid, Lichesterinic acid, Protocetraric acid, Fumarprotocetraric acid | Antitrypanosomal | Protolichesterinic acid MIC value 12.5 µM | [ | ||
| β-1,3/1,4-Glucan lichenan | Keratinocytes (NHEK) cells | Cellular differentiation | ↓ Proliferation | [ | |
| Protolichesterinic acid | A549 cells | Cytotoxic | No change in 5-lipoxygenase activity | [ | |
| Protolichesterinic acid | T-47D cells, K-562 cells and | Cytotoxic | Morphological changes in T-47D and K-562 | [ | |
| Ethanol extract | MCF7 cells | Cytotoxic | ↓ Cell viability (IC50 9.2047 × 10−5 g/mL) | [ | |
| Methanol extract | FemX and LS174 cells | Cytotoxic | FemX (IC50 22.6 μg/mL) | [ | |
| Lichenan | U937 cells | Cytotoxic | No active | [ | |
| Methanol extract | MCF-7 and HepG2 cells | Cytotoxic | MCF-7 (IC50 181.0 µg/mL) | [ | |
| Fumarprotocetraric acid | T-47D and Panc-1 | Cytotoxic | No antiproliferative effect | [ | |
| Chloroform–methanol, extract | Developing zebrafish embryos | Depigmenting | ↓ Pigmentation (IC50 44 µg/mL) | [ | |
| Chloroform–methanol extract | Radical scavenging activity | Depigmenting | Tyrosinase inhibition (IC50 86 µg/mL) | [ | |
| Aqueous extract | Human erythrocytes with type 1 diabetes mellitus | Genotoxicity | ↑ Proliferation index | [ | |
| Methanol extract | Peripheral venous blood | Genotoxicity | ↑ Number of BN cells containing MNi and number of MNi in BN cells | [ | |
| Aqueous extract | Human monocytes differentiated into mature dendritic cells. | Immunomodulating | Aqueous extract and lichenan were active | [ | |
| (1 --> 3) -(1 --> 4)-α-D-Glucan polysaccharide Ci-3 | Whole blood | Immunomodulating | ↑ Granulocytic phagocytosis | [ | |
| Fumarprotocetraric acid | Radical scavenging activity | Neuroprotective | ORAC (5.07 μmol TE/mg), DPPH (IC50 1393.83 μg/mL) | [ | |
| Methanol extract | U373 MG cells | Neuroprotective | ORAC (3.06 µmol TE/mg), DPPH (IC50 1183.55 µg/mL) | [ | |
| Methanol extract | Gram-positive: | Antibacterial | Antimicrobial activity against all bacterial strains | [ | |
| Methanol extract | Antifungal | Antifungal activity against all fungal species tested | [ | ||
| Methanol extract | Thiocyanate method | Antioxidant | 48.79% inhibition of the oxidation of linoleic acid | [ |